Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-beta.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Laboratory and Clinical Medicine

• Publication date

  2001-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1067/MLC.2001.115494PMID 11433229
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AGEs induce oxidative stress and activate protein kinase C-beta(II) in neonatal mesangial cells.

  2000cited by this paper
• LDL stimulates collagen mRNA synthesis in mesangial cells through induction of PKC and TGF-β expression.

  1999cited by this paper
• Effect of high glucose on mesangial cell protein kinase C-delta and -epsilon is polyol pathway-dependent.

  1999cited by this paper
• Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding.

  1999cited by this paper
• Glycated albumin stimulation of PKC-β activity is linked to increased collagen IV in mesangial cells.

  1999cited by this paper
• Differential expression of protein kinase C isoforms in streptozotocin-induced diabetic rats.

  1999cited by this paper
• Suppression Subtractive Hybridization Identifies High Glucose Levels as a Stimulus for Expression of Connective Tissue Growth Factor and Other Genes in Human Mesangial Cells*

  1999cited by this paper
• Effects of advanced glycation end products on cytosolic Ca2+ signaling of cultured human mesangial cells.

  1999cited by this paper
• Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells.

  1998cited by this paper
• Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: involvement of the transforming growth factor-beta system.

  1998cited by this paper
• Upregulation of Mesangial Growth Factor and Extracellular Matrix Synthesis by Advanced Glycation End Products Via a Receptor-Mediated Mechanism

  1997cited by this paper
• Nitric Oxide Inhibition of Transforming Growth Factor-β and Collagen Synthesis in Mesangial Cells

  1997cited by this paper
• Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment.

  1996cited by this paper
• Involvement of oxidation in LDL-induced collagen gene regulation in mesangial cells.

  1996cited by this paper
• Protein Kinase C: Structure, Function, and Regulation (*)

  1995cited by this paper
• Advanced glycosylation end products in diabetic renal and vascular disease.

  1995cited by this paper
• PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products.

  1995cited by this paper
• Lilly Lecture 1993. Glycation and diabetic complications.

  1994cited by this paper
• Recent progress on the biologic and clinical significance of advanced glycosylation end products.

  1994cited by this paper
• Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.

  1994cited by this paper
• Amadori glucose adducts modulate mesangial cell growth and collagen gene expression.

  1994cited by this paper
• Activation of Protein Kinase C in Glomerular Cells in Diabetes: Mechanisms and Potential Links to the Pathogenesis of Diabetic Glomerulopathy

  1994cited by this paper
• Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats.

  1994cited by this paper
• Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta.

  1994cited by this paper
• Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease.

  1994cited by this paper
• Visualization of binding and uptake of oxidized low density lipoproteins by cultured mesangial cells.

  1994cited by this paper
• PKC and high glucose stimulate collagen alpha 1 (IV) transcriptional activity in a reporter mesangial cell line.

  1994cited by this paper
• Glycation and Diabetic Complications

  1994cited by this paper
• Advanced glycosylation endproducts: Role in diabetic and non‐diabetic vascular disease

  1994cited by this paper
• Role for Protein Kinase C in the Mediation of Increased Fibronectin Accumulation by Mesangial Cells Grown in High-Glucose Medium

  1993cited by this paper
• Glucose-induced protein kinase C activity regulates arachidonic acid release and eicosanoid production by cultured glomerular mesangial cells.

  1993cited by this paper
• Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor.

  1992cited by this paper
• Immunocharacterization of δ‐ and ζ‐isoenzymes of protein kinase C in rat renal mesangial cells

  1992cited by this paper
• Immunocharacterization of delta- and zeta-isoenzymes of protein kinase C in rat renal mesangial cells.

  1992cited by this paper
• Mechanistic Studies of Advanced Glycosylation End Product Inhibition by Aminoguanidine

  1992cited by this paper
• Advanced glycosylation end products in patients with diabetic nephropathy.

  1991cited by this paper
• Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy

  1991cited by this paper
• Effects of Nonenzymatic Glycosylation of Mesangial Matrix on Proliferation of Mesangial Cells

  1991cited by this paper
• Glucose enhances type IV collagen production in cultured rat glomerular mesangial cells

  1991cited by this paper
• Retardation by Aminoguanidine of Development of Albuminuria, Mesangial Expansion, and Tissue Fluorescence in Streptozocin-Induced Diabetic Rat

  1991cited by this paper
• Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium.

  1991cited by this paper
• High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells.

  1990cited by this paper
• Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells.

  1989cited by this paper
• Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose.

  1989cited by this paper
• Isolation, purification and partial characterization of novel fluorophores from aging human insoluble collagen-rich tissue.

  1989cited by this paper
• The molecular heterogeneity of protein kinase C and its implications for cellular regulation

  1988cited by this paper
• Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.

  1988cited by this paper
• Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking.

  1986cited by this paper
• An absolute method for protein determination based on difference in absorbance at 235 and 280 nm.

  1980cited by this paper
• Effect of High Glucose on Mesangial Cell Protein Kinase C-␦ and -⑀ Is Polyol Pathway-dependent

  year unknowncited by this paper

• Fibrosis of Peritoneal Membrane as Target of New Therapies in Peritoneal Dialysis

  2022cites this paper
• Effectiveness of Magnolol, a Lignan from Magnolia Bark, in Diabetes, Its Complications and Comorbidities—A Review

  2021influential citation
• Molecular pathways in peritoneal fibrosis.

  2020cites this paper
• A potential role for glycated cross‐links in abdominal aortic aneurysm disease

  2017cites this paper
• Protective effects and mechanism of quercetin on renal injury of diabetic nephropathy rats

  2017cites this paper
• Correlation of Beta igh 3 levels with Albumin Creatinine Ratio in Type 2 Diabetic Patients

  2016cites this paper
• LDL in mesangial cells Biphasic regulation of plasminogen activator/inhibitor by

  2016cites this paper
• Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor‐β1 在晚期糖基化终末产物环境中细胞外基质通过RAGE受体依赖性途径调节，转化生长因子‐β1可以促进这种调节

  2015cites this paper
• Plasma and urinary matrix metalloproteinase-9 as a marker for detection of nephropathy in type 2 diabetic patients

  2015cites this paper
• Local membrane versus systemic consequences of peritoneal dialysis treatment

  2015cites this paper
• Pathway-Based Genome-Wide Association Studies for Plasma Triglycerides in Obese Females and Normal-Weight Controls

  2015cites this paper
• Erk5 is a mediator to TGFβ1-induced loss of phenotype and function in human podocytes

  2014cites this paper
• Advanced Glycation End Products and Diabetic Complications

  2014cites this paper
• Aquaporins: Pathophysiology and Therapeutical Impact in Peritoneal Dialysis

  2013cites this paper
• Pathogenic Role of TGF- β in Diabetic Nephropathy

  2013cites this paper
• Mechanisms and interventions in peritoneal fibrosis

  2012cites this paper
• Methylglyoxal promotes oxidative stress and endothelial dysfunction.

  2012cites this paper
• Encapsulating peritoneal sclerosis: the state of affairs

  2011cites this paper
• Role of TGF-ß in Mesangial Matrix Accumulation in Chronic Progressive Glomerular Disease

  2011cites this paper
• Encapsulating peritoneal sclerosis: the state

  2011cites this paper
• Diabetic nephropathy: Aggressive involvement of oxidative stress

  2011cites this paper
• Avaliação dos efeitos do betabloqueador nebivolol sobre o peritônio em modelo experimental murino de diálise peritoneal

  2011cites this paper
• Encapsulating Peritoneal Sclerosis in the Netherlands: A study on incidence, risk factors and clinical consequences

  2011cites this paper
• Expression of advanced glycation end products and related molecules in diabetic fibrovascular epiretinal membranes

  2010cites this paper
• Encapsulating peritoneal sclerosis

  2010cites this paper
• GLUCOSE AS A CARDIOVASCULAR COMPLICATIONS - OVERVIEW

  2010cites this paper
• Extract of Cassiae Semen and its major compound inhibit S100b-induced TGF-beta1 and fibronectin expression in mouse glomerular mesangial cells.

  2010cites this paper
• Serum carboxymethyllysine concentrations are reduced in diabetic men with abdominal aortic aneurysms: Health In Men Study.

  2009cites this paper
• Ruboxistaurin: PKC-β inhibition for complications of diabetes

  2009cites this paper
• p38MAPK and ERK promote nitric oxide production in cultured human retinal pigmented epithelial cells induced by high concentration glucose.

  2009cites this paper
• Pathophysiology of Diabetic Nephropathy: Involvement of Multifaceted Signalling Mechanism

  2009cites this paper
• KIOM-79 prevents S100b-induced TGF-beta1 and fibronectin expression in mouse mesangial cells.

  2009cites this paper
• Recent advances in pharmacotherapy for diabetic nephropathy: current perspectives and future directions.

  2009cites this paper
• Pathophysiology and management of diabetic retinopathy

  2009cites this paper
• Isoflavones Made Simple – Agonist Activity for the Beta-Type Estrogen Receptor May Mediate Their Health Benefits

  2009cites this paper
• Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells.

  2008cites this paper
• Transforming growth factor-beta induces cellular injury in experimental diabetic neuropathy.

  2008cites this paper
• Protein kinase C beta inhibitors: a new therapeutic target for diabetic nephropathy and vascular complications

  2008cites this paper
• Advanced glycation end-products in cardiac and renal failure

  2008cites this paper
• Glycated human serum albumin enhances macrophage inflammatory protein-1beta mRNA expression through protein kinase C-delta and NADPH oxidase in macrophage-like differentiated U937 cells.

  2008cites this paper
• [Molecular bases of diabetic nephropathy].

  2007cites this paper
• Glibenclamide prevents increased extracellular matrix formation induced by high glucose concentration in mesangial cells.

  2007cites this paper
• Effect of magnolol on TGF-beta1 and fibronectin expression in human retinal pigment epithelial cells under diabetic conditions.

  2007cites this paper
• Role of methylglyoxal in the pathogenesis of hypertension

  2007cites this paper
• Bases moleculares da glomerulopatia diabética

  2007cites this paper
• Peritoneal Fibrosis Intervention

  2007cites this paper
• Matrix Biology of Abdominal Aortic Aneurysms in Diabetes: Mechanisms Underlying the Negative Association

  2007cites this paper
• Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.

  2007cites this paper
• revisão Bases Moleculares da Glomerulopatia Diabética

  2007cites this paper
• ROLE OF METHYLGLYOXAL IN THE PATHOGENESIS OF

  2007cites this paper
• Effects of KIOM-79 on hyperglycemia and diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats.

  2007cites this paper
• Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits.

  2006cites this paper
• Oxidative and Glycooxidative Stress in Diabetic Nephropathy

  2006cites this paper
• Rosiglitazone prevents advanced glycation end products-induced renal toxicity likely through suppression of plasminogen activator inhibitor-1.

  2006cites this paper
• ERK contributes to the effects of Smad signaling on oxidized LDL‐induced PAI‐1 experssion in human mesangial cells

  2006cites this paper
• The John F. Maher Recipient Lecture 2004: Rage in the Peritoneum

  2005cites this paper
• Cellular Oxidative Processes in Relation to Renal Disease

  2005cites this paper
• Oxidized LDL activates PAI-1 transcription through autocrine activation of TGF-beta signaling in mesangial cells.

  2005cites this paper
• Renal clearance of glycolaldehyde- and methylglyoxal-modified proteins in mice is mediated by mesangial cells through a class A scavenger receptor (SR-A)

  2005cites this paper
• Novel interactions between TGF-{beta}1 actions and the 12/15-lipoxygenase pathway in mesangial cells.

  2005cites this paper
• The John F. Maher Recipient Lecture 2004: Rage in the peritoneum

  2005cites this paper
• Molecular Developments in the Treatment of Renal Fibrosis

  2005cites this paper
• Rôle des sphingolipides endogènes dans les modifications de la prolifération des cellules mésangiales rénales en réponse aux produits avancés de glycation (AGE) : implication dans le développement de la néphropathie diabétique

  2005cites this paper
• The role of AGEs and AGE inhibitors in diabetic cardiovascular disease.

  2005cites this paper
• RAGE‐ and TGF‐ β receptor‐mediated signals converge on STAT5 and p21waf to control cell‐cycle progression of mesangial cells: a possible role in the development and progression of diabetic nephropathy

  2004cites this paper
• Bimodal Effect of Advanced Glycation End Products on Mesangial Cell Proliferation Is Mediated by Neutral Ceramidase Regulation and Endogenous Sphingolipids*

  2004cites this paper
• Microvascular complications of diabetes.

  2004cites this paper
• Glycated Albumin Induces Superoxide Generation in Mesangial Cells

  2004cites this paper
• The role of protein kinase C activation in cardiovascular dysfunctions of diabetes and insulin resistance

  2004cites this paper
• Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway.

  2004cites this paper
• Advanced glycation end products in kidney transplant patients: a putative role in the development of chronic renal transplant dysfunction.

  2004cites this paper
• Glycated albumin activates PAI-1 transcription through Smad DNA binding sites in mesangial cells.

  2004cites this paper
• Pathogenesis of Diabetic Microvascular Complications

  2004cites this paper
• Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway.

  2004cites this paper
• In vitro evidence for immune activating effect of specific AGE structures retained in uremia.

  2004cites this paper
• Effect of an aqueous extract of Phaseolus vulgaris on the properties of tail tendon collagen of rats with streptozotocin-induced diabetes.

  2003cites this paper
• Overview of glucose signaling in mesangial cells in diabetic nephropathy.

  2003cites this paper
• Basic Mechanisms and Clinical Implications of Peritoneal Fibrosis

  2003cites this paper
• Mechanisms of cardiovascular complications in diabetes and potential new pharmacological therapies

  2003cites this paper
• Role of advanced glycation end products in diabetic nephropathy.

  2003cites this paper
• Peritoneal fibrosis and its prevention

  2002cites this paper
• Molecular understanding of hyperglycemia's adverse effects for diabetic complications.

  2002cites this paper
• Upregulation of smooth muscle cell collagen production by homocysteine-insight into the pathogenesis of homocystinuria.

  2002cites this paper
• Biphasic regulation of plasminogen activator/inhibitor by LDL in mesangial cells.

  2002cites this paper